DUDKIN; Vadim

Patent Applications and Registrations

Patent applications and USPTO patent grants for DUDKIN; Vadim.The latest application filed is for "novel tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides".

Company Profile

6.12.18

DUDKIN; Vadim - West Point PA
Dudkin; Vadim - Chalfont PA
Dudkin; Vadim - Spring House PA
Dudkin; Vadim - Lansdale PA US
Dudkin; Vadim - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Tetragalnac And Peptide Containing Conjugates And Methods For Delivery Of Oligonucleotides App 20220289785 - TELLERS; David ; et al.	2022-09-15
Site-specific conjugation of glycosylated monoclonal antibodies with transglutaminase App 20210388085 - Dudkin; Vadim ; et al.	2021-12-16
METHODS FOR SITE SPECIFIC CONJUGATION OF PROTEINS CONTAINING GLYCOSYLATED Fc DOMAINS App 20210363177 - Dudkin; Vadim ; et al.	2021-11-25
Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides Grant 11,117,917 - Tellers , et al. September 14, 2	2021-09-14
Radiolabeling Of Polypeptides App 20210017099 - Dudkin; Vadim ; et al.	2021-01-21
Macrocyclic Chelators and Methods of Use Thereof App 20200353105 - Salter; Rhys ; et al.	2020-11-12
Targeting With Firbronectin Type Iii Like Domain Molecules App 20190184028 - Dudkin; Vadim ; et al.	2019-06-20
Novel Tetragalnac And Peptide Containing Conjugates And Methods For Delivery Of Oligonucleotides App 20190153016 - TELLERS; David ; et al.	2019-05-23
Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides Grant 10,221,205 - Tellers , et al.	2019-03-05
Tetragalnac containing conjugates and methods for delivery of oligonucleotides Grant 10,214,742 - Tellers , et al. Feb	2019-02-26
Novel Tetragalnac And Peptide Containing Conjugates And Methods For Delivery Of Oligonucleotides App 20180079769 - TELLERS; David ; et al.	2018-03-22
Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides Grant 9,840,531 - Tellers , et al. December 12, 2	2017-12-12
Novel Tetragalnac And Peptide Containing Conjugates And Methods For Delivery Of Oligonucleotides App 20170306324 - TELLERS; David ; et al.	2017-10-26
Novel Tetragalnac Containing Conjugates And Methods For Delivery Of Oligonucleotides App 20170233731 - TELLERS; David ; et al.	2017-08-17
Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides Grant 9,655,976 - Tellers , et al. May 23, 2	2017-05-23
Tetragalnac containing conjugates and methods for delivery of oligonucleotides Grant 9,540,639 - Tellers , et al. January 10, 2	2017-01-10
Novel Tetragalnac And Peptide Containing Conjugates And Methods For Delivery Of Oligonucleotides App 20150246133 - Tellers; David ; et al.	2015-09-03
Novel Tetragalnac Containing Conjugates And Methods For Delivery Of Oligonucleotides App 20150203843 - Tellers; David ; et al.	2015-07-23
Ether benzotriazole derivatives Grant 8,785,481 - Beshore , et al. July 22, 2	2014-07-22
Positive allosteric modulators of MGLUR2 Grant 8,765,784 - Arrington , et al. July 1, 2	2014-07-01
Positive Allosteric Modulators Of Mglur2 App 20130210768 - Arrington; Kenneth L. ; et al.	2013-08-15
Ether Benzotriazole Derivatives App 20120135977 - Beshore; Douglas C. ; et al.	2012-05-31
High Throughput Protein Interaction Assay App 20110014226 - Caulfield; Michael J. ; et al.	2011-01-20
Prostate specific antigens and uses thereof Grant 7,645,454 - Danishefsky , et al. January 12, 2	2010-01-12
Gp120 specific antigens and uses thereof Grant 7,531,181 - Danishefsky , et al. May 12, 2	2009-05-12
Gp120 specific antigens and uses thereof App 20060229432 - Danishefsky; Samuel J. ; et al.	2006-10-12
Prostate specific antigens and uses thereof App 20060223744 - Danishefsky; Samuel J. ; et al.	2006-10-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.